Top Ten Equity Holdings and Exposures

RNS Number : 8294B
Polar Cap Gbl Healthcare Growth&IT
06 April 2017
 

6th April 2017

 

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st March 2017 and full Portfolio listing as at 28th February 2017 available from company's website

 

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31st March 2017 the top ten equity holdings and the sector and geographic breakdown were as follows:   

 

Top 10 Holdings         

%

Pfizer

7.5%

Merck & Co

7.4%

Johnson & Johnson

6.2%

Sanofi

5.2%

GlaxoSmithKline

5.0%

Novartis

4.4%

Merck KGaA

4.3%

Roche

4.0%

Astellas Pharma

3.5%

Bristol Myers Squibb

3.2%

Total

50.8%

 

 

 

Sector Exposure

%

Pharmaceuticals

58.7%

Healthcare Equipment

9.5%

Biotechnology

7.8%

Healthcare REITs

5.7%

Healthcare Services

4.3%

Healthcare Facilities

3.6%

Managed Healthcare

3.2%

Healthcare Supplies

0.8%

Life & Health Insurance

0.7%

Life Sciences Tools & Services

0.3%

Healthcare Distributors

0.2%

Cash

5.3%

Total

100.0%

 

 

 

 

 

 

 

 

Geographic Exposure

%

United States

49.4%

United Kingdom

10.2%

Switzerland

9.0%

Japan

5.7%

France

5.2%

Germany

4.8%

Australia

3.0%

Ireland

2.8%

Canada

1.9%

Denmark

0.8%

India

0.7%

Italy

0.7%

Norway

0.3%

Cash

5.3%

Total

100%

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGGDZVMGNZM
UK 100

Latest directors dealings